|
| |
 |
| |
 |
Mark
Littlewood
Career |
| 2005 |
Technology
Commercialisation Specialist,
Qi3 |
| 2004-2005 |
Business
Unit Manager – Bioreagents,
NextGen Sciences Ltd
NextGen Sciences
is a leading provider
of novel automated technologies
and software for the
proteomics and recombinant
protein research communities.
Implemented strategy
for the production of
OEM products for the
use on the robotic systems,
identifying and collaborating
with a leading US-based
supplier of molecular
biology reagents. Licensed
and successfully commercialised
novel product from University
spin out company. |
| 2003-2004 |
Key
Account Manager (Life
Science Specialist),
Sigma-Aldrich & Co
Ltd
Managed portfolio
of key clients worth
in excess of £4
Million per annum, working
closely with key purchasing
departments to implement
pricing agreements. |
| 2002-2003 |
Associate
Director Laboratory
Operations,
DNA Sciences Ltd
DNA Sciences
is a n applied genetics
company focused on the
discovery and commercialisation
of DNA based diagnostic
tests for use in clinical
trials. Led the UK laboratory
team through turbulent
period of restructuring.
Appraised and streamlined
stock control and ordering
systems. Managed contracts
with blue chip clients
from the pharmaceutical
industry. |
| 1998-2002 |
Senior
Scientist, DNA Sciences
Ltd
Returned to
live in the UK . Established
the first commercial
pharmacogenetics laboratory
in Europe , passing audits
by the MCA to gain GLP
accreditation. Responsible
for the transfer and
full validation of systems
from the US parent laboratory. |
| 1997-1998 |
Junior
Lecturer, University
of the Witwatersrand
Responsible
for the administration
of examinations for
400 medical students
and taught courses
in laboratory safety,
blood biochemistry,
membrane biology and
radiochemistry. |
| 1993-1997 |
Senior
Research Technician,
University of the Witwatersrand
Emigrated
to Johannesburg, South
Africa. Implemented
and coordinated new
student practical classes,
revolutionising student
attendance-rates. Executed
and policed upgraded
systems to ensure radiological
safety across the whole
department. |
| 1991-1993 |
Research
Assistant, University of Manchester
Purchased and
developed novel system
for the detection of
fluctuations in calcium
levels in small arteries,
using fluorescence microscopy |
| 1988-1991 |
Research
Assistant, University of Leicester
Investigated
the effects of immunosuppressant
therapy on blood pressure. |
| |
Education |
| 2004 |
Warwick Business
School
MBA (with distinction) |
| 1998 |
University
of the Witwatersrand
PhD Molecular Biology |
| 1989 |
University
of Hull
BSc Biochemistry |
|
 |
 |
| |
See also:
Advisory Board:
Associates:
Network:
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
